Sandra Gannon

Cholesterol, blood pressure products and aspirin are among those featuring in the latest update that says 307 products are now unavailable

Impact of crisis should serve as ‘wake-up call’ to policymakers, says Azure Pharmaceuticals

Authorities say a rise in supply-related shortages in Ireland is reflected across Europe

Refusal of strategy to be published this week to address pricing issues for common off-patent therapies likely only to worsen supply issues

Surge in demand this winter puts pressure on supplies amid sharp disagreement over long-term impact of pricing

Cough syrups and effervescent painkillers that are staples of family medicine cabinets are out of stock

Problems with communication are exacerbating a difficult winter as supply chain issues mean a growing number of medicines are not available

Industry executive says Ireland needs to rethink one-way approach to pricing if it is to ease pressure on pharmacies

Supply problems always relate to the low-cost market, says head of drug manufacturer

Sandra Gannon services supply chain when firms stop investing in off-patent products

Pharmaceutical companies also warn of higher costs for HSE

Industry blames State policy for problem with cutting Ireland’s medicine bill

Industry group calls for a radical overhaul of medicines policy in Ireland

Simon Harris keen to increase use of cheaper versions of off-patent medicines